Axon Enterprise, Inc. (NASDAQ:AXON) Stock Holdings Boosted by Everence Capital Management Inc.

Everence Capital Management Inc. grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 14.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,550 shares of the biotechnology company’s stock after purchasing an additional 190 shares during the quarter. Everence Capital Management Inc.’s holdings in Axon Enterprise were worth $921,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Quent Capital LLC lifted its position in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 75 shares during the last quarter. Prestige Wealth Management Group LLC boosted its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the period. Versant Capital Management Inc increased its stake in Axon Enterprise by 4,750.0% in the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock worth $58,000 after purchasing an additional 95 shares in the last quarter. Brooklyn Investment Group acquired a new stake in Axon Enterprise during the 3rd quarter worth about $41,000. Finally, Planning Capital Management Corp lifted its stake in Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 55 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on AXON shares. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. JMP Securities boosted their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Finally, Needham & Company LLC raised their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $488.67.

Axon Enterprise Stock Up 0.8 %

Axon Enterprise stock opened at $601.06 on Friday. Axon Enterprise, Inc. has a fifty-two week low of $241.72 and a fifty-two week high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm has a market cap of $45.83 billion, a price-to-earnings ratio of 155.31, a P/E/G ratio of 14.19 and a beta of 1.04. The firm has a fifty day moving average price of $593.68 and a two-hundred day moving average price of $440.17.

Insiders Place Their Bets

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the sale, the director now directly owns 26,259 shares in the company, valued at $11,500,916.82. This trade represents a 3.67 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 51,545 shares of company stock valued at $31,159,317 in the last three months. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.